Return to Search

Plan Payment

Guidance for the development and improvement of all bidding and payment policies related to the Medicare Prescription Drug Benefit and the Medicare Advantage program for the individual and employer sponsored group market.

Final

Issued by: Centers for Medicare & Medicaid Services (CMS)

Issue Date: June 17, 2020

This section provides information about the development and improvement of all bidding and payment policies related to the Medicare Prescription Drug Benefit and the Medicare Advantage program for the individual and employer sponsored group market.

HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.

DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.